reports
- ABGSC IT Research
- Oscar Rönnkvist
- Simon Jönsson
- Olfa Taamallah
- Yan Derocles
Airbus Group : Visite du site de Hambourg – En vol pour la cadence 75
>Une supply chain encore sous tension - Nous avons organisé une visite du site d’Hambourg où nous avons notamment pu échanger avec Thomas Toepfer (CFO) et Christoph Zammert (Head of A320 program). A nos yeux, les points saillants étaient les suivants. Tout d’abord, le discours sur la chaine de fournisseurs reste prudent avec, à court terme, des difficultés centrées sur les fournisseurs Tier 2/3, tout particulièrement dans les domaines de la cabine, l’APU et certains «...
- Gerardo Ibanez
- Steven Boumans
Vastned : Major changes at Vastned: Asset Sales, Synergies and Sven
>Reverse merger of Vastned Retail and Vastned Belgium and new CEO - Vastned’s management is executing its strategic plans: 1) A major step in its asset sales program had been announced earlier; 2) last week the company announced the intention to merge, which should create synergies; and 3) Vastned announced a new CEO from 2025, Sven Bosman. The announced intention to merge its Belgian and Dutch entities in a reverse cross-border merger is expected to be positive for s...
- Martin Marandon-Carlhian
- Stephane Houri
Arm Holdings plc : Arm reste le véhicule clé pour jouer la complexific...
>Opinion Surperformance réitérée, OC relevé à 130 $ (vs 110 $) - Nous avons fait le point avec la société, quelques jours après la publication du T4 23/24, et ressortons confortés sur le fait que Arm devrait continuer de croître en moyenne de 20% par an sur les 3 prochains exercices. Cette croissance découle bien, comme nous l’avions indiqué lors de notre initiation, d’un process accéléré de complexification des architectures, tirée dans un 1er temps par l’accélérati...
Assurant Inc: 2 directors
Two Directors at Assurant Inc sold 9,400 shares at between 176.122USD and 176.363USD. The significance rating of the trade was 79/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
BMS Birlesik Metal Sanayi ve Ticaret Anonim Sirketi: 2 directors
Two Directors at BMS Birlesik Metal Sanayi ve Ticaret Anonim Sirketi sold 600,000 shares at between 34.070TRY and 34.110TRY. The significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by ...
Fitness Prime: 1 director
A director at Fitness Prime bought 300,000 shares at 0.000EGP and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Hornbach Holding AG & Co KGaA: 1 director
A director at Hornbach Holding AG & Co KGaA bought 300 shares at 78.399EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
- ABGSC Oil & Oil Services Research
- Haakon Amundsen
- Stian Wibstad
Presto Automation Announces Fiscal Third Quarter 2024 Financial Result...
Presto Automation Announces Fiscal Third Quarter 2024 Financial Results Successful Pilots of Presto Voice™ with Pure AI and Spanish Language Capabilities Focuses on Voice AI Solution for Drive-Thrus By Exiting Touch Pay-at-Table Solution SAN CARLOS, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- -- (NASDAQ: ), one of the largest drive-thru AI and automation technology providers to the restaurant industry, today announced financial results for the 2024 fiscal third quarter ended March 31, 2024. “We are encouraged by the significant progress we are making in our Voice AI solution across many ...
Litchfield Hills Research reiterates buy recommendation at $10.00 per ...
Litchfield Hills Research reiterates buy recommendation at $10.00 per share New York and Bilbao, Spain, 21 May - US equity research firm Litchfield Hills Research has just published a new analysis of Virtualware (ENXTPA: MLVIR), reiterating its Buy recommendation at $10.00 per share. The report, signed by analyst Theodore R. O'Neill, reaffirms his ‘Buy’ recommendation and highlights the execution of the company's plan to achieve higher recurring revenue through SaaS subscriptions with the VIROO platform, along with its expansion in the US.He notes that ‘VIROO is becoming a g...
- ABGSC Strategy Research
- Bengt Jonassen
Moody's Ratings downgrades Agile's ratings to Ca/C; outlook remains ne...
Moody's Ratings (Moody's) has downgraded Agile Group Holdings Limited's (Agile) corporate family rating (CFR) to Ca from Caa2 and the company's senior unsecured rating to C from Caa3/Ca. Moody's has also maintained the negative outlook. "The downgrade of Agile's ratings and the negative outlook re...
Moody's Ratings downgrades Agile's ratings to Ca/C; outlook remains ne...
穆迪投资者服务公司 1*请注意新闻稿之英文原版已于香港时间5月16日发放穆迪评级下调雅居乐的评级至Ca/C；展望仍为负面 香港，2024年5月16日—中文新闻稿为英文的翻译件。如有出入，以英文稿为准。穆迪评级 (穆迪) 将雅居乐集团控股有限公司 (雅居乐) 的公司家族评级从Caa2下调至Ca，并将其高级无抵押债务评级从Caa3/Ca下调至C。与此同时，穆迪也维持其负面展望。穆迪助理副总裁/分析师周易玮表示：“雅居乐的评级下调及其负面展望反映了该公司的流动性疲弱、对利息支付违约，以及我们预计其债券持有人的回收前景较弱。”评级理据 2024年5月14日，雅居乐宣布未能在2024年5月13日结束的宽...
EQS-News: Kontron AG: Major order for smart wallboxes
EQS-News: Kontron AG / Key word(s): Development of Sales Kontron AG: Major order for smart wallboxes 21.05.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Linz, 21.05.2024: Kontron AG, a global leader in IoT technology, has been greenlit to supply smart charging stations for electric vehicles for one of the world’s largest car manufacturers. Series production will begin in July 2024. The first stage of the contract is worth at least EUR 200 million. For the development of the fully networked charging solution, the IoT speciali...
EQS-News: Kontron AG: Großauftrag für intelligente Wallboxen
EQS-News: Kontron AG / Schlagwort(e): Umsatzentwicklung Kontron AG: Großauftrag für intelligente Wallboxen 21.05.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Linz, 21.05.2024: Kontron AG, ein weltweit führender Anbieter von IoT-Technologie, hat die Freigabe zur Lieferung von intelligenten Ladestationen für Elektroautos von einem der weltweit größten Automobilhersteller erhalten. Die Serienproduktion wird im Juli 2024 beginnen. Das Auftragsvolumen beträgt im ersten Schritt zumindest 200 Millionen Euro. Bei der Entwickl...
- ABGSC Financials Research
- Jan Erik Gjerland
- Magnus Andersson
- Patrik Brattelius
Innate Pharma: Clarification concernant le statut de SAR443579
MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé aujourd’hui qu’un abstract publié le 14 mai 2024 en amont du congrès de l’Association Européenne d’Hématologie 2024 (European Hematology Association – EHA), soumis par Sanofi, mentionne que SAR443579/IPH6101 aurait reçu le statut de « Breakthrough Designation ». Cette information est erronée. Comme communiqué précédemment, la molécule a reçu le statut « Fast Track » de la Food and Drug Administration (FDA), l’agence américaine des médicaments ...
Innate Pharma: Clarification Regarding SAR443579 Designation
MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by Sanofi, it was mentioned that the molecule received breakthrough designation. This is an error. The molecule has US FDA Fast Track Designation, as communicated before in June 2023. About ANKET® (Antibody-based NK cell Engager Therapeutics) is Innate's proprietary platform for developing next-generation, mul...
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific O...
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer Saint-Herblain (France), May 21, 2024 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the appointment of Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer (CSO) and Executive Committee member, effective June 3, 2024. Valneva decided to complement its Executive Team with an accomplished R&D leader to oversee the further evolution of the Company´s R&D portfolio. Specifically, Dr. Schuitemaker will focus on accelerating Valneva’s pre-clinical and translational R&D activi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.